XML 45 R34.htm IDEA: XBRL DOCUMENT v3.19.2
Commitments and Contingencies (Details Narrative) - USD ($)
1 Months Ended 9 Months Ended 12 Months Ended
Dec. 02, 2018
Nov. 27, 2019
Aug. 22, 2017
Dec. 31, 2011
Apr. 30, 2019
Nov. 16, 2012
Apr. 23, 2019
Apr. 08, 2019
Feb. 15, 2019
Feb. 04, 2019
Jan. 24, 2019
Nov. 25, 2018
Oct. 26, 2018
Jul. 31, 2018
Commitments and Contingencies     The letter from AEXG counsel claimed that Generex’s acceptance of $3,000,000 in financing from Pharma Trials, LLC, in March 2017, violated the provisions of the MOU prohibiting Generex from seeking other financing, with certain exceptions, for a period of 60 days after execution of the MOU. AEXG has demanded at least $210,000 in cash and 84,000 warrants for Generex stock convertible at $2.50 per share, for attorney’s fees and costs.                      
Rental payments, 2019                           $ 44,700
Rental Payment, 2020                           82,469
Rental payment, 2021                           $ 9,403
Litigation awards for damages $ 315,695                          
Litigation awards, exercisable shares 84,000                          
Exercise price $ 2.50                          
Note amount             $ 530,000 $ 530,000 $ 750,000 $ 750,000 $ 2,110,000 $ 1,060,000 $ 682,000  
Value of the warrants         $ 65,613                  
Liquidated damages         220,000                  
Accrued Liquidated damages         $ 285,613                  
Alternative Execution Group [Member]                            
Memorandum of Understanding description The petition includes a demand of $3,300,360 as the value of the Warrants. The arbitrator did not award the specific amount of $3.3 million, but only liquidated damages in the amount of $220,000 and the value of 84,000 warrants “as of today” (the date of the award) plus attorney’s fees, certain costs, prejudgment and post-judgment interest (which continues to run on a daily basis) and arbitration fees. Generex has responded that the value of the warrants on the date of the award is $0 or some figure far less than the value calculated by AEXG. The petition to confirm the arbitrator’s award and Generex’s opposition are pending before the Court for a decision.                          
Olaregen                            
Intellectual property acquired   $ 650,000                        
Damages for Unpaid Invoices                            
Value of damages sought       $ 429,000                    
Lawsuit filing date       31-Dec-11                    
Name of Plaintiff       Vendor                    
Settlement of litigation           $ 125,000                
Interest per annum, failure to pay settlement       3.00%                    
Fixed cost per annum, failure to pay settlement       $ 25,000                    
Breach of contract and detinue                            
Counterclaim proceeding       $ 200,000